Ticker Details
BioLife Solutions, Inc. BioLife Solutions Inc manufactures proprietary and generic cGMP biopreservation media products, generic formulations of blood stem cell freezing media products, custom product formulation packaging services and contract aseptic manufacturing formulation.
IPO Date:	October 1, 2002
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$1.11B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.47 | 2.96%
Avg Daily Range (30 D):	$0.46 | 1.96%
Avg Daily Range (90 D):	$0.45 | 1.79%

Institutional Daily Volume
Avg Daily Volume:	.23M
Avg Daily Volume (30 D):	.26M
Avg Daily Volume (90 D):	.26M

Trade Size
Avg Trade Size (Sh.):	75
Avg Trade Size (Sh.) (30 D):	47
Avg Trade Size (Sh.) (90 D):	44

Institutional Trades
Total Institutional Trades:	1,536
Avg Institutional Trade:	$1.56M
Avg Institutional Trade (30 D):	$1.07M
Avg Institutional Trade (90 D):	$1.48M
Avg Institutional Trade Volume:	.06M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.58M
Avg Closing Trade (30 D):	$1.23M
Avg Closing Trade (90 D):	$1.5M
Avg Closing Volume:	59.26K

News

Feb 17, 2026 @ 1:04 PM BioLife Solutions to Report Fourth Quarter and Ful... Source: Prnewswire

Feb 12, 2026 @ 1:03 PM BioLife Solutions Signs Multi-Year Supply Agreemen... Source: Prnewswire

Feb 11, 2026 @ 6:40 PM Bio-Preservation Market to Reach US$ 44.45 Billion... Source: Astute Analytica

Jan 12, 2026 @ 1:03 PM BioLife Solutions Announces Preliminary Fourth Qua... Source: Prnewswire

Dec 11, 2025 @ 1:03 PM BioLife Solutions' CFO Sells 30,000 Shares Source: Lawrence Rothman, Cfa

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS		$.01	$-.33
Diluted EPS		$.01	$-.33
Revenue		$28.07M	$25.42M
Gross Profit
Net Income / Loss		$.62M	$-15.84M
Operating Income / Loss		$-.09M	$-16.64M
Cost of Revenue
Net Cash Flow		$-2.42M	$-35.04M
PE Ratio

Splits
Jan 29, 2014	1:14